Form 4 for MEDS DataMeds AI, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0001641172-25-000553 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-21 | MEDS | ANDERSON DONALD WILLIAM | Dir | A - Grant | $0.00 | +200.0K | 244.7K | +447% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 200,000 | $0.00 | 244,720 | D | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 66,000 shares vesting immediately, 67,000 shares vesting on March 4, 2026, and 67,000 shares vesting on March 4, 2027. |